|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Antisense oligonucleotide therapy has shown some promise in treating stroke causes that are genetically determined and resistant to classic prevention approaches such as elevated lipoprotein (a) and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
|
30635869 |
2019 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Lipoprotein(a) and other ASCVD risk factors were measured at baseline (1996-1998) in the biracial Atherosclerosis Risk in Communities study; participants without prevalent ASCVD (coronary heart disease or stroke) were monitored ∼15 years for incident ASCVD events.
|
30685442 |
2019 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Serum lipoprotein(a) and risk of hemorrhagic stroke among incident peritoneal dialysis patients: a large study from a single center in China.
|
31498021 |
2019 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Previous studies have examined the association of lipoprotein(a) and risk of stroke; however, the results are conflicting.
|
31272552 |
2019 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Serum lipoprotein (a) is associated with increased risk of stroke in Chinese adults: A prospective study.
|
31437611 |
2019 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Objective- Increased Lp(a) [lipoprotein(a)] is associated with coronary heart disease risk, but links with stroke are less consistent.
|
30786745 |
2019 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
In recent prospective studies, high Lp(a) [lipoprotein(a)] level is associated with high risk of stroke but low risk of Alzheimer disease.
|
31597550 |
2019 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
High concentrations of plasma lipoprotein(a) [Lp(a)] have been inferred to be an independent risk factor for cardiovascular and cerebrovascular diseases, such as coronary artery diseases, restenosis, and stroke.
|
29064597 |
2018 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Lipoprotein(a) Lp(a) is a cholesterol-rich, LDL-like particle that is independently associated with an increased risk for ischemic heart disease, atherosclerosis, thrombosis, and stroke.
|
28608522 |
2018 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
This study aims to determine lipoprotein (a) [Lp(a)] levels in serum and to investigate their associations with stroke recurrence events in a 3-month follow-up study in patients with acute ischemic stroke (AIS).
|
28004340 |
2018 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
GWASCAT |
Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants.
|
24262325 |
2014 |
|
Cerebrovascular accident
|
0.500 |
AlteredExpression
|
group |
BEFREE |
Increased levels of lipoprotein(a) are known as an independent risk factor for atherosclerosis, heart disease, and stroke in man.
|
23546733 |
2013 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Various prothrombotic risk factors have been investigated in pediatric stroke including elevated homocysteine and lipoprotein (a), antithrombin, protein C and protein S deficiency, Factor V Leiden, Factor II G20210A and plasminogen activator inhibitor-1 4G/5G polymorphism.
|
23092062 |
2012 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
The comparable strength of associations of the LPA score with coronary disease and peripheral vascular disease but not with stroke suggest that lipoprotein(a) may have effects on atherothrombotic vascular disease that are only relevant at specific sites.
|
21252144 |
2011 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
High plasma concentrations of lipoprotein(a) [Lp(a), which is encoded by the APOA gene] increase an individual's risk of developing diseases, such as coronary artery diseases, restenosis, and stroke.
|
21804189 |
2011 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Lipoprotein(a) [Lp(a)] is an established risk factor for coronary disease and stroke, but mechanisms underlying this association are unknown.
|
21078622 |
2011 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Increased levels of lipoprotein(a) (Lp[a])are known independent risk factor for atherosclerosis, heart disease, and stroke in adults.
|
22187404 |
2011 |
|
Cerebrovascular accident
|
0.500 |
GeneticVariation
|
group |
BEFREE |
Multiple regression analyses for all subjects (n=90) showed that being a stroke patient (p<0.0001), fibrinogen (p<0.0001) and lipoprotein(a) (p=0.0075) were independent predictors of clot permeability (model R2 0.79).
|
19942259 |
2010 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Valproic acid can increase lipoprotein(a) and decrease fibrinogen, which may increase the risk of stroke or other thrombotic events.
|
19135623 |
2009 |
|
Cerebrovascular accident
|
0.500 |
AlteredExpression
|
group |
LHGDN |
Effect of aspirin on lipoprotein(a) in patients with ischemic stroke.
|
17845920 |
2007 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
LHGDN |
Lipoprotein (a) and stroke: a meta-analysis of observational studies.
|
17478739 |
2007 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
Most children with pediatric stroke have more than one risk factor, mainly vasculopathies or elevation of lipoprotein(a).
|
17675027 |
2007 |
|
Cerebrovascular accident
|
0.500 |
AlteredExpression
|
group |
LHGDN |
Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population.
|
17145597 |
2006 |
|
Cerebrovascular accident
|
0.500 |
AlteredExpression
|
group |
LHGDN |
Serum lipoprotein(a) levels and apolipoprotein(a) isoform size and risk for first-ever acute ischaemic nonembolic stroke in elderly individuals.
|
16197951 |
2006 |
|
Cerebrovascular accident
|
0.500 |
Biomarker
|
group |
BEFREE |
At least 3 months after stroke, the concentrations of total cholesterol (TC), HDL cholesterol (HDL-C), LDL cholesterol (LDL-C), triglycerides (TGs), apolipoprotein E (apoE), and lipoprotein (a) [lp(a)] were measured and LDL phenotypes and apoE isoforms were identified.
|
12972382 |
2003 |